menu
    • menu

    Company profile for Theravance Biopharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Theravance Biopharma is a diversified biopharmaceutical company with the core purpose of creating medicines that make a difference in the lives of patients suffering from serious illness.Our pipeline of internally discovered product candidates includes potential best-in-class medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting. VIBATIV® (telavancin), our fi...
    Theravance Biopharma is a diversified biopharmaceutical company with the core purpose of creating medicines that make a difference in the lives of patients suffering from serious illness.Our pipeline of internally discovered product candidates includes potential best-in-class medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting. VIBATIV® (telavancin), our first commercial product, is a once-daily dual-mechanism antibiotic approved in the U.S., Europe and certain other countries for certain difficult-to-treat infections.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Theravance BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    901 Gateway Boulevard South San Francisco, CA 94080
    Telephone
    Telephone
    650-808-6000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.theravance.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Theravance Bio To Host Virtual Investor Event On Ampreloxetine
    Theravance Bio To Host Virtual Investor Event On Ampreloxetine

    20 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-to-host-virtual-kol-investor-event-to-review-ampreloxetine-phase-3-clinical-development-program-ahead-of-topline-data-in-q1-2026-on-december-8-2025-302621860.html

    PR NEWSWIRE
    20 Nov 2025
    Share Share
    Theravance Bio To Join Investor Conferences
    Theravance Bio To Join Investor Conferences

    19 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-to-participate-in-upcoming-investor-conferences-302619765.html

    PR NEWSWIRE
    19 Nov 2025
    Share Share
    Theravance Bio Reports Q3 2025 Financials & Corporate Update
    Theravance Bio Reports Q3 2025 Financials & Corporate Update

    11 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-inc-reports-third-quarter-2025-financial-results-and-provides-corporate-update-302610645.html

    PR NEWSWIRE
    11 Nov 2025
    Share Share
    Theravance Bio to Share Ampreloxetine Data at Symposium
    Theravance Bio to Share Ampreloxetine Data at Symposium

    29 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-to-present-data-on-ampreloxetine-at-the-36th-international-symposium-on-the-autonomic-nervous-system-302597901.html

    PR NEWSWIRE
    29 Oct 2025
    Share Share
    Theravance Bio To Release Q3 2025 Financial Results On Nov 10
    Theravance Bio To Release Q3 2025 Financial Results On Nov 10

    27 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-to-report-third-quarter-2025-financial-results-on-november-10-2025-302594981.html

    PR NEWSWIRE
    27 Oct 2025
    Share Share
    Theravance Sets Up Noh Awareness Campaign Ahead Of Pivotal Data
    Theravance Sets Up Noh Awareness Campaign Ahead Of Pivotal Data

    20 Oct 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/theravance-stands-physician-education-campaign-ahead-pivotal-data

    FIERCE PHARMA
    20 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search